| Literature DB >> 30201117 |
Patricia Navarro-Rodríguez1, Marcela Guevara-Suarez2, Katihuska Paredes1, Adriana Celis3, Josep Guarro1, Javier Capilla4.
Abstract
The efficacy of liposomal amphotericin B and voriconazole was evaluated against the systemic infection by Fusarium oxysporum species complex or Fusarium keratoplasticum. Although MIC values were within the epidemiological cutoff values (ECVs) recently stablished for Fusarium spp., no efficacy was obtained, indicating that ECVs for Fusarium are not relevant for in vivo efficacy.Entities:
Keywords: Animal model; Antifungal therapy; Fusariosis; Fusarium; Liposomal amphotericin B; Voriconazole
Mesh:
Substances:
Year: 2018 PMID: 30201117 DOI: 10.1016/j.diagmicrobio.2018.05.019
Source DB: PubMed Journal: Diagn Microbiol Infect Dis ISSN: 0732-8893 Impact factor: 2.803